Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
Add more filters










Publication year range
1.
Int J Biochem Cell Biol ; 45(10): 2158-62, 2013 Oct.
Article in English | MEDLINE | ID: mdl-23769948

ABSTRACT

The eukaryotic initiation factor 3 subunit f (eIF3f) is one of the 13 subunits of the translation initiation factor complex eIF3 required for several steps in the initiation of mRNA translation. In skeletal muscle, recent studies have demonstrated that eIF3f plays a central role in skeletal muscle size maintenance. Accordingly, eIF3f overexpression results in hypertrophy through modulation of protein synthesis via the mTORC1 pathway. Importantly, eIF3f was described as a target of the E3 ubiquitin ligase MAFbx/atrogin-1 for proteasome-mediated breakdown under atrophic conditions. The biological importance of the MAFbx/atrogin-1-dependent targeting of eFI3f is highlighted by the finding that expression of an eIF3f mutant insensitive to MAFbx/atrogin-1 polyubiquitination is associated with enhanced protection against starvation-induced muscle atrophy. A better understanding of the precise role of this subunit should lead to the development of new therapeutic approaches to prevent or limit muscle wasting that prevails in numerous physiological and pathological states such as immobilization, aging, denervated conditions, neuromuscular diseases, AIDS, cancer, diabetes. This article is part of a Directed Issue entitled: Molecular basis of muscle wasting.


Subject(s)
Eukaryotic Initiation Factor-3/metabolism , Muscle Proteins/metabolism , Muscle, Skeletal/pathology , Muscular Atrophy/metabolism , Animals , Cell Proliferation , Eukaryotic Initiation Factor-3/genetics , Humans , Muscle Proteins/genetics , Muscle, Skeletal/metabolism , Muscular Atrophy/genetics , Muscular Atrophy/pathology , Protein Biosynthesis , Signal Transduction
2.
PLoS One ; 5(2): e8994, 2010 Feb 01.
Article in English | MEDLINE | ID: mdl-20126553

ABSTRACT

The mTORC1 pathway is required for both the terminal muscle differentiation and hypertrophy by controlling the mammalian translational machinery via phosphorylation of S6K1 and 4E-BP1. mTOR and S6K1 are connected by interacting with the eIF3 initiation complex. The regulatory subunit eIF3f plays a major role in muscle hypertrophy and is a key target that accounts for MAFbx function during atrophy. Here we present evidence that in MAFbx-induced atrophy the degradation of eIF3f suppresses S6K1 activation by mTOR, whereas an eIF3f mutant insensitive to MAFbx polyubiquitination maintained persistent phosphorylation of S6K1 and rpS6. During terminal muscle differentiation a conserved TOS motif in eIF3f connects mTOR/raptor complex, which phosphorylates S6K1 and regulates downstream effectors of mTOR and Cap-dependent translation initiation. Thus eIF3f plays a major role for proper activity of mTORC1 to regulate skeletal muscle size.


Subject(s)
Eukaryotic Initiation Factor-3/metabolism , Intracellular Signaling Peptides and Proteins/metabolism , Myoblasts, Skeletal/metabolism , Protein Serine-Threonine Kinases/metabolism , Ribosomal Protein S6 Kinases, 90-kDa/metabolism , Signal Transduction , Animals , Binding Sites/genetics , Blotting, Western , Cell Differentiation , Cell Enlargement , Cells, Cultured , Eukaryotic Initiation Factor-3/genetics , Intracellular Signaling Peptides and Proteins/genetics , Lysine/genetics , Lysine/metabolism , Male , Mechanistic Target of Rapamycin Complex 1 , Mice , Multiprotein Complexes , Muscle Proteins/genetics , Muscle Proteins/metabolism , Mutation , Myoblasts, Skeletal/cytology , Protein Binding , Protein Biosynthesis , Protein Serine-Threonine Kinases/genetics , Proteins , RNA Interference , Ribosomal Protein S6 Kinases, 90-kDa/genetics , SKP Cullin F-Box Protein Ligases/genetics , SKP Cullin F-Box Protein Ligases/metabolism , Satellite Cells, Skeletal Muscle/cytology , Satellite Cells, Skeletal Muscle/metabolism , TOR Serine-Threonine Kinases , Transcription Factors/genetics , Transcription Factors/metabolism , Transfection
3.
PLoS One ; 4(3): e4973, 2009.
Article in English | MEDLINE | ID: mdl-19319192

ABSTRACT

Ubiquitin ligase Atrogin1/Muscle Atrophy F-box (MAFbx) up-regulation is required for skeletal muscle atrophy but substrates and function during the atrophic process are poorly known. The transcription factor MyoD controls myogenic stem cell function and differentiation, and seems necessary to maintain the differentiated phenotype of adult fast skeletal muscle fibres. We previously showed that MAFbx mediates MyoD proteolysis in vitro. Here we present evidence that MAFbx targets MyoD for degradation in several models of skeletal muscle atrophy. In cultured myotubes undergoing atrophy, MAFbx expression increases, leading to a cytoplasmic-nuclear shuttling of MAFbx and a selective suppression of MyoD. Conversely, transfection of myotubes with sh-RNA-mediated MAFbx gene silencing (shRNAi) inhibited MyoD proteolysis linked to atrophy. Furthermore, overexpression of a mutant MyoDK133R lacking MAFbx-mediated ubiquitination prevents atrophy of mouse primary myotubes and skeletal muscle fibres in vivo. Regarding the complex role of MyoD in adult skeletal muscle plasticity and homeostasis, its rapid suppression by MAFbx seems to be a major event leading to skeletal muscle wasting. Our results point out MyoD as the second MAFbx skeletal muscle target by which powerful therapies could be developed.


Subject(s)
Muscle Proteins/metabolism , MyoD Protein/metabolism , SKP Cullin F-Box Protein Ligases/metabolism , Animals , Cells, Cultured , Gene Knockout Techniques , Mice , Muscle Fibers, Skeletal/cytology , Muscle Proteins/antagonists & inhibitors , Muscle Proteins/genetics , Muscular Atrophy/prevention & control , Mutation , SKP Cullin F-Box Protein Ligases/antagonists & inhibitors , SKP Cullin F-Box Protein Ligases/genetics
4.
J Biol Chem ; 284(7): 4413-21, 2009 Feb 13.
Article in English | MEDLINE | ID: mdl-19073596

ABSTRACT

We recently presented evidence that the subunit eIF3-f of the eukaryotic initiation translation factor eIF3 that interacts with the E3-ligase Atrogin-1/muscle atrophy F-box (MAFbx) for polyubiquitination and proteasome-mediated degradation is a key target that accounts for MAFbx function during muscle atrophy. To understand this process, deletion analysis was used to identify the region of eIF3-f that is required for its proteolysis. Here, we report that the highly conserved C-terminal domain of eIF3-f is implicated for MAFbx-directed polyubiquitination and proteasomal degradation. Site-directed mutagenesis of eIF3-f revealed that the six lysine residues within this domain are required for full polyubiquitination and degradation by the proteasome. In addition, mutation of these six lysines (mutant K(5-10)R) displayed hypertrophic activity in cellulo and in vivo and was able to protect against starvation-induced muscle atrophy. Taken together, our data demonstrate that the C-terminal modifications, believed to be critical for proper eIF3-f regulation, are essential and contribute to a fine-tuning mechanism that plays an important role for eIF3-f function in skeletal muscle.


Subject(s)
Eukaryotic Initiation Factor-3/metabolism , Lysine/metabolism , Muscle Proteins/metabolism , Muscle, Skeletal/metabolism , Muscular Atrophy/metabolism , SKP Cullin F-Box Protein Ligases/metabolism , Animals , Cell Line , Eukaryotic Initiation Factor-3/genetics , Lysine/genetics , Mice , Muscle Proteins/genetics , Muscle, Skeletal/pathology , Muscular Atrophy/genetics , Muscular Atrophy/pathology , Mutagenesis, Site-Directed , Proteasome Endopeptidase Complex/genetics , Proteasome Endopeptidase Complex/metabolism , Protein Structure, Tertiary/genetics , SKP Cullin F-Box Protein Ligases/genetics , Starvation/genetics , Starvation/metabolism , Starvation/pathology , Ubiquitination/genetics
5.
Cell Cycle ; 7(12): 1698-701, 2008 Jun 15.
Article in English | MEDLINE | ID: mdl-18583931

ABSTRACT

The control of muscle cell size is a physiological process balanced by a fine tuning between protein synthesis and protein degradation. MAFbx/Atrogin-1 is a muscle specific E3 ubiquitin ligase upregulated during disuse, immobilization and fasting or systemic diseases such as diabetes, cancer, AIDS and renal failure. This response is necessary to induce a rapid and functional atrophy. To date, the targets of MAFbx/Atrogin-1 in skeletal muscle remain to be identified. We have recently presented evidence that eIF3-f, a regulatory subunit of the eukaryotic translation factor eIF3 is a key target that accounts for MAFbx/Atrogin-1 function in muscle atrophy. More importantly, we showed that eIF3-f acts as a "translational enhancer" that increases the efficiency of the structural muscle proteins synthesis leading to both in vitro and in vivo muscle hypertrophy. We propose that eIF3-f subunit, a mTOR/S6K1 scaffolding protein in the IGF-1/Akt/mTOR dependent control of protein translation, is a positive actor essential to the translation of specific mRNAs probably implicated in muscle hypertrophy. The central role of eIF3-f in both the atrophic and hypertrophic pathways will be discussed in the light of its promising potential in muscle wasting therapy.


Subject(s)
Eukaryotic Initiation Factor-3/chemistry , Eukaryotic Initiation Factor-3/physiology , Muscle, Skeletal/metabolism , Muscle, Skeletal/pathology , Muscular Atrophy/metabolism , Protein Biosynthesis , Animals , Eukaryotic Initiation Factor-3/antagonists & inhibitors , Humans , Hypertrophy , Muscle Proteins/chemistry , Muscle Proteins/metabolism , Muscle, Skeletal/growth & development , Muscular Atrophy/etiology , Muscular Atrophy/genetics , Protein Kinases/metabolism , Protein Subunits/physiology , Ribosomal Protein S6 Kinases/metabolism , SKP Cullin F-Box Protein Ligases/chemistry , SKP Cullin F-Box Protein Ligases/metabolism , Signal Transduction , TOR Serine-Threonine Kinases , Wasting Syndrome/therapy
6.
Exp Cell Res ; 312(20): 3999-4010, 2006 Dec 10.
Article in English | MEDLINE | ID: mdl-17014844

ABSTRACT

The transcription factors MyoD and Myf5 present distinct patterns of expression during cell cycle progression and development. In contrast to the mitosis-specific disappearance of Myf5, which requires a D-box-like motif overlapping the basic domain, here we describe a stable and inactive mitotic form of MyoD phosphorylated on its serine 5 and serine 200 residues by cyclin B-cdc2. In mitosis, these modifications are required for releasing MyoD from condensed chromosomes and inhibiting its DNA-binding and transcriptional activation ability. Then, nuclear MyoD regains instability in the beginning of G1 phase due to rapid dephosphorylation events. Moreover, a non-phosphorylable MyoD S5A/S200A is not excluded from condensed chromatin and alters mitotic progression with apparent abnormalities. Thus, the drop of MyoD below a threshold level and its displacement from the mitotic chromatin could present another window in the cell cycle for resetting the myogenic transcriptional program and to maintain the myogenic determination of the proliferating cells.


Subject(s)
Cell Division , G2 Phase , Mitosis , Muscle Cells/metabolism , MyoD Protein/metabolism , Animals , CDC2 Protein Kinase/metabolism , Cell Line , Chromosomes/genetics , Chromosomes/metabolism , Cyclin B/metabolism , Mice , MyoD Protein/physiology , Phosphorylation , Proteasome Endopeptidase Complex/metabolism , Serine/chemistry , Transfection , Ubiquitin/metabolism
7.
J Biol Chem ; 280(4): 2847-56, 2005 Jan 28.
Article in English | MEDLINE | ID: mdl-15531760

ABSTRACT

MyoD controls myoblast identity and differentiation and is required for myogenic stem cell function in adult skeletal muscle. MyoD is degraded by the ubiquitin-proteasome pathway mediated by different E3 ubiquitin ligases not identified as yet. Here we report that MyoD interacts with Atrogin-1/MAFbx (MAFbx), a striated muscle-specific E3 ubiquitin ligase dramatically up-regulated in atrophying muscle. A core LXXLL motif sequence in MyoD is necessary for binding to MAFbx. MAFbx associates with MyoD through an inverted LXXLL motif located in a series of helical leucine-charged residue-rich domains. Mutation in the LXXLL core motif represses ubiquitination and degradation of MyoD induced by MAFbx. Overexpression of MAFbx suppresses MyoD-induced differentiation and inhibits myotube formation. Finally the purified recombinant SCF(MAFbx) complex (SCF, Skp1, Cdc53/Cullin 1, F-box protein) mediated MyoD ubiquitination in vitro in a lysine-dependent pathway. Mutation of the lysine 133 in MyoD prevented its ubiquitination by the recombinant SCF(MAFbx) complex. These observations thus demonstrated that MAFbx functions in ubiquitinating MyoD via a sequence found in transcriptional coactivators. These transcriptional coactivators mediate the binding to liganded nuclear receptors. We also identified a novel protein-protein interaction module not yet identified in F-box proteins. MAFbx may play an important role in the course of muscle differentiation by determining the abundance of MyoD.


Subject(s)
MyoD Protein/chemistry , SKP Cullin F-Box Protein Ligases/physiology , Amino Acid Motifs , Amino Acid Sequence , Animals , Cell Differentiation , Cell Line , DNA/metabolism , Humans , Immunoblotting , Immunoprecipitation , Lysine/chemistry , Mice , Microscopy, Fluorescence , Models, Genetic , Molecular Sequence Data , Muscle, Skeletal/metabolism , MyoD Protein/metabolism , Phosphorylation , Protein Binding , Protein Structure, Tertiary , Recombinant Proteins/chemistry , Reverse Transcriptase Polymerase Chain Reaction , SKP Cullin F-Box Protein Ligases/metabolism , Sequence Homology, Amino Acid , Stem Cell Factor/metabolism , Time Factors , Transcription, Genetic , Transfection , Two-Hybrid System Techniques , Ubiquitin/metabolism
8.
Mol Cell Biol ; 24(4): 1809-21, 2004 Feb.
Article in English | MEDLINE | ID: mdl-14749395

ABSTRACT

The transcription factors MyoD and Myf-5 control myoblast identity and differentiation. MyoD and Myf-5 manifest opposite cell cycle-specific expression patterns. Here, we provide evidence that MyoD plays a pivotal role at the G(2)/M transition by controlling the expression of p21(Waf1/Cip1) (p21), which is believed to regulate cyclin B-Cdc2 kinase activity in G(2). In growing myoblasts, MyoD reaccumulates during G(2) concomitantly with p21 before entry into mitosis; MyoD is phosphorylated on Ser5 and Ser200 by cyclin B-Cdc2, resulting in a decrease of its stability and down-regulation of both MyoD and p21. Inducible expression of a nonphosphorylable MyoD A5/A200 enhances the MyoD interaction with the coactivator P/CAF, thereby stimulating the transcriptional activation of a luciferase reporter gene placed under the control of the p21 promoter. MyoD A5/A200 causes sustained p21 expression, which inhibits cyclin B-Cdc2 kinase activity in G(2) and delays M-phase entry. This G(2) arrest is not observed in p21(-/-) cells. These results show that in cycling cells MyoD functions as a transcriptional activator of p21 and that MyoD phosphorylation is required for G(2)/M transition.


Subject(s)
CDC2 Protein Kinase/metabolism , Mitosis , Mutation/genetics , MyoD Protein/genetics , MyoD Protein/metabolism , Animals , Cell Line , Cyclin B/metabolism , Cyclin-Dependent Kinase Inhibitor p21 , Cyclins/metabolism , G2 Phase , Gene Expression Regulation , Histone Deacetylase 1 , Histone Deacetylases , Mice , Models, Biological , Muscle, Skeletal , MyoD Protein/chemistry , Myoblasts/cytology , Myoblasts/enzymology , Myoblasts/metabolism , Phosphorylation , Phosphoserine/metabolism , Protein Binding , Time Factors , Transcriptional Activation
9.
J Biol Chem ; 279(7): 5413-20, 2004 Feb 13.
Article in English | MEDLINE | ID: mdl-14660660

ABSTRACT

The ubiquitin-proteasome system is responsible for the regulation and turnover of the nuclear transcription factor MyoD. The degradation of MyoD can occur via an NH2 terminus-dependent pathway or a lysine-dependent pathway, suggesting that MyoD ubiquitination may be driven by different mechanisms. To understand this process, deletion analysis was used to identify the region of MyoD that is required for rapid proteolysis in the lysine-dependent pathway. Here we report that the basic helix-loop-helix domain is required for ubiquitination and lysine-dependent degradation of MyoD in the nucleus. Site-directed mutagenesis in MyoD revealed that lysine 133 is the major internal lysine of ubiquitination. The half-life of the MyoD K133R mutant protein was longer than that of wild type MyoD, substantiating the implication of lysine 133 in the turnover of MyoD in myoblasts. In addition, the MyoD K133R mutant displayed activity 2-3-fold higher than the wild type in transactivation muscle-specific gene and myogenic conversion of 10T1/2 cells. Taken together, our data demonstrate that lysine 133 is targeted for ubiquitination and rapid degradation of MyoD in the lysine-dependent pathway and plays an integral role in compromising MyoD activity in the nucleus.


Subject(s)
Cell Nucleus/metabolism , Lysine/chemistry , MyoD Protein/metabolism , Ubiquitin/metabolism , Amino Acid Sequence , Animals , Blotting, Western , Cell Line , Cycloheximide/pharmacology , DNA/chemistry , DNA, Complementary/metabolism , Enzyme Inhibitors/pharmacology , Gene Deletion , Genetic Vectors , Luciferases/metabolism , Lysine/physiology , Mice , Molecular Sequence Data , Mutagenesis, Site-Directed , Mutation , Plasmids/metabolism , Precipitin Tests , Protein Structure, Tertiary , Protein Synthesis Inhibitors/pharmacology , Time Factors , Transcriptional Activation , Transfection , Ubiquitin/chemistry
10.
Blood ; 103(3): 1059-68, 2004 Feb 01.
Article in English | MEDLINE | ID: mdl-14525786

ABSTRACT

Acute myeloid leukemia (AML) is sustained by the extensive proliferation of leukemic stem and progenitor cells, which give rise to the population of leukemic blasts with defective differentiation and low proliferative capacity. We have recently shown that ligation of CD44, a cell surface molecule present on AML cells, with specific monoclonal antibodies (mAbs) inhibits their proliferation. However, its mechanism has not been investigated yet. Here, using the NB4 cell line as a model of proliferating human AML cells, and the A3D8 mAb to ligate CD44, we show for the first time that CD44 ligation stabilizes the cyclin-dependent kinase inhibitor p27(Kip1) (p27) protein, resulting in increased association with cyclin E/Cdk2 complexes and inhibition of their kinase activity. Moreover, using a p27 antisense vector, we provide direct evidence that p27 is the main mediator of cell growth arrest by CD44. CD44 ligation also leads to p27 accumulation in THP-1, KG1a, and HL60 cell lines and in primary leukemic cells, suggesting that this process is general in AML. Taken together, our present results suggest that CD44 is a new and efficient means to increase the expression of p27 in AML cells. Considering that elevated expression of p27 is a factor of good prognosis in AML, these results provide a new basis for developing CD44-targeted therapy in AML.


Subject(s)
Cell Cycle Proteins/metabolism , Hyaluronan Receptors/metabolism , Leukemia, Myeloid, Acute/immunology , Leukemia, Myeloid, Acute/metabolism , Tumor Suppressor Proteins/metabolism , Antibodies, Monoclonal , CDC2-CDC28 Kinases/metabolism , Cell Cycle , Cell Cycle Proteins/genetics , Cell Division/drug effects , Cell Line, Tumor , Cyclin E/metabolism , Cyclin-Dependent Kinase 2 , Cyclin-Dependent Kinase Inhibitor p27 , Drug Stability , Humans , Hyaluronic Acid/pharmacology , In Vitro Techniques , Leukemia, Myeloid, Acute/pathology , Transfection , Tumor Suppressor Proteins/genetics
11.
Oncogene ; 22(36): 5658-66, 2003 Aug 28.
Article in English | MEDLINE | ID: mdl-12944914

ABSTRACT

Rhabdomyosarcoma (RMS) has deregulated proliferation and is blocked in the differentiation program despite Myf-5, MyoD and myogenin expression. Here we show that ectopic expression of MRF4, which is not subject to an autoregulatory pathway but regulated by the other MRFs protein family, induces growth arrest and terminal differentiation in RD cells. Deletion mapping identified a positive-acting C-terminal domain in MRF4 as the mediator of transcriptional activity, revealing a conserved motif with helix III in MyoD previously found to initiate expression of endogenous skeletal muscle genes. By using chimeric MyoD/MRF4 proteins, we observe that the C-terminal motif of MRF4 rescues MyoD activity in RD cells. Moreover, comparative induction of muscle-specific genes following activation of MyoD, through the expression of a constitutively activated MKK6 either in the absence or presence of MRF4, shows that MyoD and MRF4 can differently regulate muscle genes expression. Together, these results demonstrate that the MRF4 C-terminus functions as specification as well as activation domain in tumor cells. They provide a basis to identify gene products necessary for b-HLH-mediated differentiation versus tumor progression.


Subject(s)
Cell Differentiation , Muscles/cytology , Myogenic Regulatory Factors/physiology , Rhabdomyosarcoma/pathology , Amino Acid Motifs , Amino Acid Sequence , Cell Line , Cyclin-Dependent Kinase Inhibitor p21 , Cyclin-Dependent Kinase Inhibitor p57 , Cyclins/physiology , Gene Expression Regulation , Humans , Molecular Sequence Data , MyoD Protein/physiology , Myogenic Regulatory Factors/chemistry , Myogenin/physiology , Nuclear Proteins/physiology
12.
FEBS Lett ; 543(1-3): 125-8, 2003 May 22.
Article in English | MEDLINE | ID: mdl-12753918

ABSTRACT

The cyclin-dependent kinase inhibitor p57(Kip2) is required for normal mouse embryonic development. p57(Kip2) consists of four structurally distinct domains in which the conserved C-terminal nuclear targeting domain contains a putative Cdk phosphorylation site (Thr(342)) that shares a great similitude in the adjacent sequences with p27(Kip1) but not with p21(Cip1). Phosphorylation on Thr(187) has been shown to promote degradation of p27(Kip1). Although there is sequence homology between the C-terminal part of p27(Kip1) and p57(Kip2), we show that the ubiquitination and degradation of p57(Kip2) are independent of Thr(342). In contrast a destabilizing element located in the N-terminal is implicated in p57(Kip2) destabilization.


Subject(s)
Cyclin-Dependent Kinases/metabolism , Nuclear Proteins/chemistry , Nuclear Proteins/metabolism , Ubiquitins/metabolism , Amino Acid Sequence , Animals , Cell Line , Consensus Sequence , Cyclin-Dependent Kinase Inhibitor p57 , Cysteine Endopeptidases/metabolism , Mice , Molecular Sequence Data , Multienzyme Complexes/metabolism , Muscle, Skeletal/cytology , Muscle, Skeletal/enzymology , Muscle, Skeletal/metabolism , Phosphorylation , Proteasome Endopeptidase Complex , Protein Structure, Tertiary , Threonine/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...